182 related articles for article (PubMed ID: 10731938)
21. [Magnetic resonance in the study of residual mediastinal masses after therapy of lymphoma].
Davini O; Levis A; Garabello D; Foggetti MD; Depaoli L; Cirillo R; De Lucchi R; Orsucci L; Resegotti L
Radiol Med; 1992 Mar; 83(3):230-6. PubMed ID: 1579671
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's disease in Indian children: outcome with chemotherapy alone.
Arya LS; Dinand V; Thavaraj V; Bakhshi S; Dawar R; Rath GK; Singh R; Vats TS
Pediatr Blood Cancer; 2006 Jan; 46(1):26-34. PubMed ID: 16161019
[TBL] [Abstract][Full Text] [Related]
23. Mediastinal Hodgkin disease in children: response to therapy.
Luker GD; Siegel MJ
Radiology; 1993 Dec; 189(3):737-40. PubMed ID: 8234698
[TBL] [Abstract][Full Text] [Related]
24. Results of lung irradiation for Hodgkin's disease patient with large mediastinal masses and/or hilar disease.
Lee CK; Bloomfield CD; Levitt SH
Cancer Treat Rep; 1982 Apr; 66(4):819-25. PubMed ID: 7074653
[TBL] [Abstract][Full Text] [Related]
25. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
26. Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scan.
Brice P; Rain JD; Frija J; Miaux Y; Marolleau JP; Tredaniel J; Ferme C; Hennequin C; Gisselbrecht C
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):457-61. PubMed ID: 8414967
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
[TBL] [Abstract][Full Text] [Related]
28. Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy.
Vigouroux S; Milpied N; Andrieu JM; Colonna P; Ifrah N; Colombat P; Desablens B; Abgrall JF; Casassus P; Guilhot F; Briere J; Le Mevel A; Moreau P; Mechinaud F; Mahe B; Morineau N; Vigier M; Rapp MJ; Harousseau JL
Bone Marrow Transplant; 2002 May; 29(10):833-42. PubMed ID: 12058233
[TBL] [Abstract][Full Text] [Related]
29. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
30. Hodgkin's lymphoma in adults--clinical features.
Jose BO; Koerner P; Spanos WJ; Paris KJ; Silverman CL; Yashar C; Carrascosa LB
J Ky Med Assoc; 2005 Jan; 103(1):15-7. PubMed ID: 15682982
[TBL] [Abstract][Full Text] [Related]
31. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
32. Childhood mediastinal masses in infants and children.
Tansel T; Onursal E; Dayloğlu E; Başaran M; Sungur Z; Qamci E; Yilmazbayhan D; Eker R; Ertuğrul T
Turk J Pediatr; 2006; 48(1):8-12. PubMed ID: 16562779
[TBL] [Abstract][Full Text] [Related]
33. [Mediastinal Hodgkin's disease and non-Hodgkin lymphoma in childhood].
Kuleva SA
Vopr Onkol; 2002; 48(6):735-7. PubMed ID: 12530278
[TBL] [Abstract][Full Text] [Related]
34. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
[TBL] [Abstract][Full Text] [Related]
35. [The clinical characteristics of treatment-resistant forms of lymphogranulomatosis in children].
Kolygin BA; Kobikov SKh
Vopr Onkol; 1990; 36(7):841-5. PubMed ID: 2399666
[TBL] [Abstract][Full Text] [Related]
36. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.
Weiner M; Leventhal B; Cantor A; Wimmer R; Berry DL; Cook B; Ducos R
Cancer; 1991 Dec; 68(11):2478-80. PubMed ID: 1933785
[TBL] [Abstract][Full Text] [Related]
37. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I
Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
[TBL] [Abstract][Full Text] [Related]
38. Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Advani R; Maeda L; Lavori P; Quon A; Hoppe R; Breslin S; Rosenberg SA; Horning SJ
J Clin Oncol; 2007 Sep; 25(25):3902-7. PubMed ID: 17664458
[TBL] [Abstract][Full Text] [Related]
39. [Complications in children cured from Hodgkin's disease].
Stachowicz-Stencel T; Bien E; Adamkiewicz-Drozynska E; Szolkiewicz A; Kuziemski K; Lass P; Stefanowicz J; Sierota D; Polczynska K; Birkholz D; Hennig M; Balcerska A
Med Wieku Rozwoj; 2006; 10(3 Pt 1):613-21. PubMed ID: 17317892
[TBL] [Abstract][Full Text] [Related]
40. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML
J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
